It is known that MTHFR is one of the central regulatory enzymes in the folate metabolism, and it is likely that not only folate deficiency, but also functional polymorphisms in genes associated with the folate-mediated homocysteine pathway, may contribute to the risk of CHDs [35]. This evidence concerns the gene MTHFR and folate deficiency.